Mini International Neuropsychiatric Interview 7.0 Pdf 38

1 view
Skip to first unread message
Message has been deleted

Rubie Mccloughan

unread,
Jul 9, 2024, 11:40:52 AM7/9/24
to mepoolviver

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short structured diagnostic interview, developed jointly by psychiatrists and clinicians in the United States and Europe, for DSM-IV and ICD-10 psychiatric disorders. With an administration time of approximately 15 minutes, it was designed to meet the need for a short but accurate structured psychiatric interview for multicenter clinical trials and epidemiology studies and to be used as a first step in outcome tracking in nonresearch clinical settings. The authors describe the development of the M.I.N.I. and its family of interviews: the M.I.N.I.-Screen, the M.I.N.I.-Plus, and the M.I.N.I.-Kid. They report on validation of the M.I.N.I. in relation to the Structured Clinical Interview for DSM-III-R, Patient Version, the Composite International Diagnostic Interview, and expert professional opinion, and they comment on potential applications for this interview.

mini international neuropsychiatric interview 7.0 pdf 38


Download https://urloso.com/2yMLxr



The Mini-International Neuropsychiatric Interview (MINI) is a short, structured diagnostic interview used as a tool to diagnose 16 axis I (Diagnostic and Statistical Manual) DSM-IV disorders and one personality disorder. Its original version was developed by Sheehan and Lecrubier. We translated the MINI into Japanese, and investigated the reliability and validity of the Japanese version of MINI. Eighty-two subjects participated in the validation of the MINI versus the Structured Clinical Interview for DSM-III-R (SCID-P). One hundred and sixty-nine subjects participated in the validation of the MINI versus an expert's professional opinion. Seventy-seven subjects were interviewed by two investigators and subsequently readministered by a third interviewer blind to the results of initial evaluation 1-2 days later. In general, kappa values indicated good or excellent agreement between MINI and SCID-P diagnoses. Kappa values indicated poor agreement between MINI and expert's diagnoses for most diagnoses. Interrater and test-retest reliabilities were good or excellent. The mean durations of the interview were 18.8 min for MINI and 45.4 min for corresponding sections of SCID-P. Overall, the results suggest that the MINI Japanese version succeeds in reliably and validly eliciting symptom criteria used in making DSM-III-R diagnoses, and can be performed in less than half the time required for the SCID-P.

Be confident that you are using the Mini International Neuropsycyhiatric Interview (MINI) correctly. Purchase directly from the author and Copyright Holder, Dr. David V Sheehan. Look for the QR code linking to HarmResearch.org to make sure you are using the MINI directly from the Copyright Holder and to get training or consultation or more information.

The Mini International Neuropsychiatric Interview (MINI) was designed as a brief structured diagnostic interview for the major psychiatric disorders in DSM-III-R, DSM-IV and DSM-5 and ICD-10. Validation and reliability studies have been done comparing the MINI to the SCID-P for DSM-III-R and the CIDI (a structured interview developed by the World Health Organization). The results of these studies show that the MINI has similar reliability and validity properties to both these instruments, but can be administered in a much shorter period of time (mean 18.7 11.6 minutes, median 15 minutes) than the above referenced instruments. Clinicians can use it after a brief training session. Lay interviewers require more extensive training. The MINI has been translated into over 70 languages.

The standard MINI assesses the 17 most common disorders in mental health. The disorders investigated are the most important to identify in clinical and research settings. The disorders were selected based on current prevalence rates of 0.5% or higher in the general population in epidemiology studies. In the interest of brevity, it uses branching tree logic.

There are several versions of the MINI available. The standard version of the MINI meets most needs, most of the time, in both clinical and research settings. The non-standard versions are mainly for use in settings where more detail is needed for some disorders, that are not captured in the standard version. Each of those versions is described below.

The MINI for Psychotic Disorders Studies has a more detailed set of questions for each of the 9 Psychotic Disorders than the standard MINI. It is suitable for clinical and research settings where Psychotic Disorders are a focus of interest and where it is important to differentiate between the different psychotic disorders (e.g. schizophrenia vs schizoaffective disorder). The standard MINI does assess both Major Depressive Disorder with Psychotic Features and Bipolar I Disorder with Psychotic Features. Otherwise all the other modules are similar to the standard MINI.

The MINI for ADHD Studies has a more detailed set of questions for each of the 9 Psychotic Disorders than the standard MINI. It is suitable for clinical and research settings where Psychotic Disorders are a focus of interest and where it is important to differentiate between the different psychotic disorders (e.g. schizophrenia vs schizoaffective disorder). The standard MINI does assess both Major Depressive Disorder with Psychotic Features and Bipolar I Disorder with Psychotic Features. Otherwise all the other modules are similar to the standard MINI.

The MINI for Suicidality Disorders Studies* has a detailed set of questions / modules on each of the 12 Suicidality Disorders phenotypes. It has more detailed modules on each of the Suicidality Disorder phenotypes beyond the questions assessing overall suicidality in the standard MINI. It is suitable for clinical and research settings where Suicidality Disorders phenotyping is a focus of interest and where it is important to differentiate between the different suicidality disorders phenotypes (e.g. Impulse Attack Suicidality Disorder vs. Psychotic Suicidality Disorder vs. Mood Disorder Induced Suicidality Disorder). Otherwise all the other modules are similar to the standard MINI.

has a detailed set of questions that probe Borderline Personality Disorder features in adults. These questions are not included in the Standard Adult MINI. This version of the MINI is suitable for clinical and research settings where adult Borderline Personality Disorder features are a focus of interest. Otherwise, all the other modules are similar to the Standard Adult MINI.

The MINI Screen uses only the screening questions in each module of the MINI. A negative response to the screening questions usually means it is unlikely the patient has a major psychiatric disorder. A positive response to any questions in the MINI Screen prompts the clinician to ask additional questions using the standard MINI. The MINI screen is on 2 pages.

Dr. Sheehan can design customized additional optional modules for the MINI for other disorders to meet the needs of a specific study or clinical setting. Contact Dr. Sheehan at davidV...@gmail.com to discuss a customized version designed for your needs.

Dr. Sheehan licenses the MINI in paper format for distribution as follows : 1) in paper format for any uses; or 2) in fixed pdf form, paper form, or both for use in clinical or academic research trials or studies.

To license the Adult MINI or MINI Tracking for use there is a charge of $15 per single administration (not per patient enrolled) for non-customized versions. The amount must be paid in full before study initiation. (click here to download a copy of this license agreement)

To license the MINI Screen or MINI Kid Screen for use there is a charge of $4 per single administration (not per patient enrolled). The amount must be paid in full before study initiation. (click here to download a copy of this license agreement)

For certain sites, Dr. Sheehan can do an additional live Zoom question and answer session to address issues encountered after the raters at the site have done a dozen or so with real patients. Please contact: davidV...@gmail.com

The non-profit Mapi Research Trust (MAPI) / ICON Language Services, in Lyon, France, is the sole translation service for existing non-English translations for all rating scales and diagnostic interviews that Dr. Sheehan licenses and distributes directly under a license from him.

When Dr. Sheehan fully executes your license agreement request, he will provide you with the information to contact MAPI / Icon Language Services to obtain consistent and conceptually equivalent, and linguistically validated translations and the related certificates.

Schizophrenia is a chronic psychotic disorder with a worldwide lifetime prevalence of 0.30% to 0.66% (McGrath et al. 2008). According to the Diagnostic and Statistical Manual for Mental Disorders (5th ed.; DSM-5) (American Psychiatric Association 2013), at least two of the following symptoms should be present to diagnose schizophrenia: delusions, hallucinations, disorganized speech, disorganized or catatonic behavior and negative symptoms. Additionally, at least one has to be from the first three symptoms. Due to the complexity of psychiatric disorders, clinical interviews are essential to confirm diagnoses in clinical and research settings. Examples of such structured interviews are the structured clinical interview for DSM (SCID) (Spitzer et al. 1992), the World Health Organization (WHO)-Composite International Diagnostic Interview (CIDI) (Wittchen 1994), the Schedule for Affective Disorders and Schizophrenia (SADS) (Endicott and Spitzer 1978), and the Mini International Neuropsychiatric Interview (MINI) (Sheehan et al. 1998).

b1e95dc632
Reply all
Reply to author
Forward
0 new messages